Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$4.64

+0.43%

Mkt Cap $308.24M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (14 analysts)

$10.00

Range $10.00$10.00

Implied Upside

+115.5%

Consensus $10.00 vs current $4.64